Rhonda Farnum

Direttore Tecnico/Scientifico/R&S presso THERAVANCE BIOPHARMA, INC.

Patrimonio netto: 3 M $ in data 31/05/2024

59 anni

Health Technology

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Dean Mitchell	M	68	THERAVANCE BIOPHARMA, INC.	10 anni
Eran Broshy	M	65	THERAVANCE BIOPHARMA, INC.	10 anni
Deepa Pakianathan	M	59	THERAVANCE BIOPHARMA, INC.	4 anni
Susannah Gray	F	63	THERAVANCE BIOPHARMA, INC.	1 anni
Rick Winningham	M	64	THERAVANCE BIOPHARMA, INC.	11 anni
Jim Kelly	M	43	THERAVANCE BIOPHARMA, INC.	1 anni
Donal O'Connor	M	73	THERAVANCE BIOPHARMA, INC.	9 anni
Laurie Alsup	M	70	THERAVANCE BIOPHARMA, INC.	6 anni
Jeremy Grant	M	36	THERAVANCE BIOPHARMA, INC.	1 anni
Richard Graham	M	-	THERAVANCE BIOPHARMA, INC.	-
Brett Grimaud	M	50	THERAVANCE BIOPHARMA, INC.	3 anni
Aziz Sawaf	M	42	THERAVANCE BIOPHARMA, INC.	10 anni
Aine Miller	M	47	THERAVANCE BIOPHARMA, INC.	-
Stacy Pryce	F	-	THERAVANCE BIOPHARMA, INC.	-
Stuart Knight	M	-	THERAVANCE BIOPHARMA, INC.	10 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Pablo Cagnoni	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 anni
Susan Molineaux	M	70	THERAVANCE BIOPHARMA, INC.	7 anni
Gail B. Cohen	F	-	THERAVANCE BIOPHARMA, INC.	2 anni
Sriram Ryali	M	43	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 anni
Renée Galá	F	52	THERAVANCE BIOPHARMA, INC.	5 anni
Brett K. Haumann	M	54	THERAVANCE BIOPHARMA, INC.	7 anni
Asif Ali	M	50	THERAVANCE BIOPHARMA, INC.	4 anni
Robert Gunderson	M	72	THERAVANCE BIOPHARMA, INC.	8 anni
Peter S. Ringrose	M	78	THERAVANCE BIOPHARMA, INC.	7 anni
George M. Whitesides	M	84	THERAVANCE BIOPHARMA, INC.	8 anni
Bradford J. Shafer	M	63	THERAVANCE BIOPHARMA, INC.	7 anni
William Young	M	79	THERAVANCE BIOPHARMA, INC.	10 anni
Burt Malkiel	M	90	THERAVANCE BIOPHARMA, INC.	11 anni
Sujay Kango	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 anni
Kanya Rajangam	M	50	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 anni
Alexander Dobbin	M	-	THERAVANCE BIOPHARMA, INC.	3 anni
Shehnaaz Suliman	M	52	THERAVANCE BIOPHARMA, INC.	2 anni
Barbara Klencke	M	66	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 anni
Vijay Sabesan	M	51	THERAVANCE BIOPHARMA, INC.	7 anni
Andrew Hindman	M	51	THERAVANCE BIOPHARMA, INC.	3 anni
Rosh Dias	M	-	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 anni
Francesco Galimi	M	56	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 anni
Jeff Knight	M	52	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	3 anni
Jane Chung	F	53	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 anni
Dana Pizzuti	M	68	THERAVANCE BIOPHARMA, INC.	-
Bill Tan	M	-	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 anni
Robert Goeltz	M	51	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	42	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni